December 2020 - Cancer Currents Blog
-
New on NCI’s Websites for December 2020NCI periodically provides updates on new websites and other online content of interest to the cancer community. See selected content that has been added as of December 2020.
-
Steroids May Limit the Effectiveness of Immunotherapy for Brain CancerIn people with glioblastoma and other brain cancers, steroids appear to limit the effectiveness of immunotherapy drugs, a new study shows. The findings should influence how steroids are used to manage brain tumor symptoms, researchers said.
-
Fertility Preservation Safe for Young Women with Breast CancerFertility preservation for young women with breast cancer doesn’t increase their risk of dying in the ensuing decades, a new study affirmed. Experts said the findings support routinely offering fertility preservation to patients who want it.
-
SARS-CoV-2 Antibodies Can Protect from Reinfection, NCI Study SuggestsIn a study using data from more than 3 million people, NCI researchers have found that people who have antibodies to SARS-CoV-2, the virus that causes COVID-19, appear to have some degree of protection against being reinfected with the virus.
-
Stopping TKI Treatment Is Safe, Improves Quality of Life for Some with CMLFor adults with CML who are in a sustained deep molecular remission, stopping treatment with a tyrosine kinase inhibitor is safe and improves their quality of life, a study shows. But researchers cautioned that these patients must be closely monitored.
-
Could Cholesterol-Lowering Drugs Improve Cancer Immunotherapy?Cholesterol-lowering drugs known as PCSK9 inhibitors may improve the effectiveness of cancer immune checkpoint inhibitors, according to studies in mice. The drugs appear to improve the immunotherapy drugs’ ability to find tumors and slow their growth.
-
Nanoparticle Trains Immune Cells to Attack CancerResearchers have developed a nanoparticle that trains immune cells to attack cancer. According to the NCI-funded study, the nanoparticle slowed the growth of melanoma in mice and was more effective when combined with an immune checkpoint inhibitor.